Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol Adjuvant Therapy in Major Depressive Disorder
NCT07574060Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- May 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 3 trial of allopurinol in major depressive disorder (MDD), sponsored by Tanta University. Started May 2026; status: recruiting.
02
Drugs
allopurinol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07574060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07574060.